A carregar...

Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.

BACKGROUND: Recent circumstantial evidence suggests that an increasing number of Iranian patients with cutaneous leishmaniasis are unresponsive to meglumine antimoniate (Glucantime), the first line of treatment in Iran. This study was designed to determine whether the clinical responses (healing, or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ramtin Hadighi, Mehdi Mohebali, Patrick Boucher, Homa Hajjaran, Ali Khamesipour, Marc Ouellette
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science (PLoS) 2006-05-01
Colecção:PLoS Medicine
Acesso em linha:http://europepmc.org/articles/PMC1435779?pdf=render
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!